
    
      The purpose of this study is to 1) evaluate the economic burden, safety and outcomes of three
      uterine-conserving treatment alternatives for symptomatic uterine fibroids: myomectomy,
      uterine artery embolization (UAE), and global fibroid ablation (GFA) using the Acessaâ„¢
      System, and 2) meet the requirements of the U.S. Food and Drug Administration's 522 Order for
      post market surveillance In this study, subjects who have symptomatic uterine fibroids will
      be randomized to one of three uterine-conserving treatments based on the local standard of
      care.
    
  